PLYGF (PolyPeptide Group AG) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 08, 2026)


PLYGF PolyPeptide Group AG PLYGF
61 GF Score
Price $43.00
GF Value $40.58
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PolyPeptide Group AG 5-Year Yield-on-Cost %?

PolyPeptide Group AG PLYGF 61 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus rates PLYGF with a GF Score™ of 61/100 and a GF Value™ of $40.58 (Fairly Valued). The stock has 8 warning signs investors should review. Among 517 Drug Manufacturers companies, PolyPeptide Group AG ranks worse than 193423.4% on this metric.

PolyPeptide Group AG's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for PolyPeptide Group AG's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 8 years, PolyPeptide Group AG's highest Yield on Cost was 1.76. The lowest was 0.00. And the median was 1.41.


PLYGF's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.27
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

PolyPeptide Group AG  (OTCPK:PLYGF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

PolyPeptide Group AG 5-Year Yield-on-Cost % Related Terms

PLYGF vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PolyPeptide Group AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PolyPeptide Group AG 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PolyPeptide Group AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where PolyPeptide Group AG's 5-Year Yield-on-Cost % falls into.


PLYGF
61GF Score
PolyPeptide Group AG PLYGF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPeptide Group AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of PolyPeptide Group AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
PolyPeptide Group AG (PLYGF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PolyPeptide Group AG and its competitors. According to the industry distribution chart, PolyPeptide Group AG ranks #999999 out of 517 companies in the Drug Manufacturers industry.
Is PolyPeptide Group AG's 5-Year Yield-on-Cost % too high?
PolyPeptide Group AG's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, PolyPeptide Group AG ranks #999999 out of 517 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PolyPeptide Group AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PolyPeptide Group AG ranks #999999 out of 517 companies for 5-Year Yield-on-Cost %. This places PolyPeptide Group AG in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.27, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PolyPeptide Group AG and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PolyPeptide Group AG's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (PLYGF) is currently considered Fairly Valued. The stock's GF Value™ is $40.58, compared to a current price of $43.00 — trading 6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. PolyPeptide Group AG's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For PolyPeptide Group AG (PLYGF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (PLYGF) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of $43.00 is trading 6% above its estimated GF Value™ of $40.58. GuruFocus considers PolyPeptide Group AG to be Fairly Valued.

Key valuation signals for PLYGF:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $40.58 vs. price of $43.00 (6% above fair value)
  • GF Score™: 61/100 with 8 warning signs

No single metric tells the full story. See the PLYGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
61GF Score

Get the complete analysis for PLYGF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.00
Price
$40.58
GF Value